ViaNase - Treating Central Nervous System (CNS) Disorders
Researchers and scientists have spent the last 25 years trying and failing to develop effective treatments for brain diseases. The majority of the traditional treatments methods available can’t bypass the blood brain barrier, leaving the majority of the medication behind in the nasal cavity, sinuses, or GI tract. Other methods also can produce a number of undesirable side effects. ViaNase™ Intelligent Delivery holds the key to overcoming this frustrating obstacle. This modified approach to treating Central Nervous System disorders uses Kurve Therapeutics’ patented Controlled Particle Dispersion technology to deliver medication precisely where it is needed, providing relief and a sense of wellbeing for patients battling brain disease.
- Reduction in systemic side effects
- Enhances the opportunity for bioavailability
- Non-invasive / painless
- Odorless / tasteless
- User-friendly
- Increased patient compliance
- Convenient / portable
- Lightweight / pocket-sized
- Battery powered
- Fast and easy to administer
The Cost of Doing Nothing
The cumulative physical, emotional, and financial effect of Central Nervous System (CNS) disorders on patients and their caretakers is utterly devastating. The latest data projects that by 2025, the number of people suffering from Alzheimer’s alone is set to increase by 22%–putting enormous strain on our healthcare system, not to mention the families who care for their aging loved ones.
What does an investment in Kurve Therapeutics mean?
- 121 million Americans currently in the cognitive aging market
- $ 257 billion In productivity loss among friends and family providing unpaid care for Alzheimer’s patients in 2020
- $600 billion The total national cost of caring for Alzheimer’s and dementia patients annually in the U.S.